MedicarePartD.guide

A non-government resource built from CMS public data

XOLREMDI 100 mg Capsule, Gelatin Coated

Also known as Mavorixafor. Coverage in Alaska (CMS PDP Region 34).

2 of 9 stand-alone Part D plans in Alaska cover this drug on tier 5.

2 of 2 plans apply a prior authorization, step therapy or quantity limit.

Every plan that covers it

PlanTier30-day preferred90-day mailUnit costEst. 30-day fillRestrictions
AARP Medicare Rx Saver from UHC (PDP)$53.20/mo premium · $615.00 deductible5Specialty Tier25%—$397.4226$4,769.0712 units
  • Prior authorization
  • Quantity limit 12 per 30 days
AARP Medicare Rx Preferred from UHC (PDP)$100.20/mo premium · $130.00 deductible5Specialty Tier31%—$397.4226$4,769.0712 units
  • Prior authorization
  • Quantity limit 12 per 30 days

Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.

See coverage in all 39 regions →